These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10568423)

  • 21. Reduced folate carrier-1 80G>A polymorphism affects methotrexate treatment outcome in rheumatoid arthritis.
    Drozdzik M; Rudas T; Pawlik A; Gornik W; Kurzawski M; Herczynska M
    Pharmacogenomics J; 2007 Dec; 7(6):404-7. PubMed ID: 17325736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Folic acid supplementation prevents deficient blood folate levels and hyperhomocysteinemia during longterm, low dose methotrexate therapy for rheumatoid arthritis: implications for cardiovascular disease prevention.
    Morgan SL; Baggott JE; Lee JY; Alarcón GS
    J Rheumatol; 1998 Mar; 25(3):441-6. PubMed ID: 9517760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Folate supplementation in methotrexate-treated rheumatoid arthritis patients.
    Stewart KA; Mackenzie AH; Clough JD; Wilke WS
    Semin Arthritis Rheum; 1991 Apr; 20(5):332-8. PubMed ID: 2068578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors for abnormal hepatic enzyme elevation by methotrexate treatment in patients with rheumatoid arthritis: A hospital based-cohort study.
    Hakamata J; Hashiguchi M; Kaneko Y; Yamaoka K; Shimizu M; Maruyama J; Takeuchi T; Mochizuki M
    Mod Rheumatol; 2018 Jul; 28(4):611-620. PubMed ID: 29252093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transaminase Levels and Hepatic Events During Tocilizumab Treatment: Pooled Analysis of Long-Term Clinical Trial Safety Data in Rheumatoid Arthritis.
    Genovese MC; Kremer JM; van Vollenhoven RF; Alten R; Scali JJ; Kelman A; Dimonaco S; Brockwell L
    Arthritis Rheumatol; 2017 Sep; 69(9):1751-1761. PubMed ID: 28597609
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intermittent rises in plasma homocysteine in patients with rheumatoid arthritis treated with higher dose methotrexate.
    Hoekstra M; Haagsma CJ; Doelman CJ; van de Laar MA
    Ann Rheum Dis; 2005 Jan; 64(1):141-3. PubMed ID: 15608313
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperhomocysteinemia in rheumatoid arthritis: influence of methotrexate treatment and folic acid supplementation.
    Jensen OK; Rasmussen C; Mollerup F; Christensen PB; Hansen H; Ekelund S; Thulstrup AM
    J Rheumatol; 2002 Aug; 29(8):1615-8. PubMed ID: 12180718
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Folate supplementation during methotrexate therapy for rheumatoid arthritis.
    Morgan SL; Baggott JE
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S102-9. PubMed ID: 21044441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk of elevated liver enzymes associated with TNF inhibitor utilisation in patients with rheumatoid arthritis.
    Sokolove J; Strand V; Greenberg JD; Curtis JR; Kavanaugh A; Kremer JM; Anofrei A; Reed G; Calabrese L; Hooper M; Baumgartner S; Furst DE;
    Ann Rheum Dis; 2010 Sep; 69(9):1612-7. PubMed ID: 20448284
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Folate, homocysteine, and cobalamin status in patients with rheumatoid arthritis treated with methotrexate, and the effect of low dose folic acid supplement.
    Hornung N; Ellingsen T; Stengaard-Pedersen K; Poulsen JH
    J Rheumatol; 2004 Dec; 31(12):2374-81. PubMed ID: 15570637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Longitudinal measurement of methotrexate liver concentrations does not correlate with liver damage, clinical efficacy, or toxicity during a 3.5 year double blind study in rheumatoid arthritis.
    Fathi NH; Mitros F; Hoffman J; Straniero N; Labreque D; Koehnke R; Furst DE
    J Rheumatol; 2002 Oct; 29(10):2092-8. PubMed ID: 12375317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The significance of AST changes in patients with rheumatoid arthritis treated with methotrexate.
    Heathcote J
    J Rheumatol; 1996 Mar; 23(3):413-5. PubMed ID: 8832974
    [No Abstract]   [Full Text] [Related]  

  • 33. The C677T mutation in the methylenetetrahydrofolate reductase gene: a genetic risk factor for methotrexate-related elevation of liver enzymes in rheumatoid arthritis patients.
    van Ede AE; Laan RF; Blom HJ; Huizinga TW; Haagsma CJ; Giesendorf BA; de Boo TM; van de Putte LB
    Arthritis Rheum; 2001 Nov; 44(11):2525-30. PubMed ID: 11710708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thymidylate synthase genetic polymorphism and plasma total homocysteine level in a group of Turkish patients with rheumatoid arthritis: relationship with disease activity and methotrexate toxicity.
    Borman P; Taşbaş Ö; Karabulut H; Tukun A; Yorgancıoğlu R
    Rev Bras Reumatol; 2015; 55(6):485-92. PubMed ID: 25687398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 677C>T and 1298A>C MTHFR polymorphisms affect methotrexate treatment outcome in rheumatoid arthritis.
    Kurzawski M; Pawlik A; Safranow K; Herczynska M; Drozdzik M
    Pharmacogenomics; 2007 Nov; 8(11):1551-9. PubMed ID: 18034620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Folate supplementation and methotrexate.
    Dijkmans BA
    Br J Rheumatol; 1995 Dec; 34(12):1172-4. PubMed ID: 8608361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between cumulative methotrexate dose, non-invasive scoring system and hepatic fibrosis detected by Fibroscan in rheumatoid arthritis patients receiving methotrexate.
    Lertnawapan R; Chonprasertsuk S; Siramolpiwat S
    Int J Rheum Dis; 2019 Feb; 22(2):214-221. PubMed ID: 30565876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preliminary evidence shows that folic acid fortification of the food supply is associated with higher methotrexate dosing in patients with rheumatoid arthritis.
    Arabelovic S; Sam G; Dallal GE; Jacques PF; Selhub J; Rosenberg IH; Roubenoff R
    J Am Coll Nutr; 2007 Oct; 26(5):453-5. PubMed ID: 17914133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adverse effects of low dose methotrexate in rheumatoid arthritis patients.
    Gilani ST; Khan DA; Khan FA; Ahmed M
    J Coll Physicians Surg Pak; 2012 Feb; 22(2):101-4. PubMed ID: 22313647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A retrospective study of serum KL-6 levels during treatment with biological disease-modifying antirheumatic drugs in rheumatoid arthritis patients: a report from the Ad Hoc Committee for Safety of Biological DMARDs of the Japan College of Rheumatology.
    Takamura A; Hirata S; Nagasawa H; Kameda H; Seto Y; Atsumi T; Dohi M; Koike T; Miyasaka N; Harigai M
    Mod Rheumatol; 2013 Mar; 23(2):297-303. PubMed ID: 22572888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.